======= GCNT2 ======= == Gene Information == * **Official Symbol**: GCNT2 * **Official Name**: glucosaminyl (N-acetyl) transferase 2 (I blood group) * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=2651|2651]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q8N0V5|Q8N0V5]] * **Interactions**: [[https://thebiogrid.org/search.php?search=GCNT2&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20GCNT2|Open PubMed]] * **OMIM**: [[https://omim.org/entry/600429|Open OMIM]] == Function Summary == * **Entrez Summary**: This gene encodes the enzyme responsible for formation of the blood group I antigen. The i and I antigens are distinguished by linear and branched poly-N-acetyllactosaminoglycans, respectively. The encoded protein is the I-branching enzyme, a beta-1,6-N-acetylglucosaminyltransferase responsible for the conversion of fetal i antigen to adult I antigen in erythrocytes during embryonic development. Mutations in this gene have been associated with adult i blood group phenotype. Alternatively spliced transcript variants encoding different isoforms have been described. [provided by RefSeq, Jul 2008]. * **UniProt Summary**: Branching enzyme that converts linear into branched poly-N-acetyllactosaminoglycans. Introduces the blood group I antigen during embryonic development. It is closely associated with the development and maturation of erythroid cells. {ECO:0000269|PubMed:7579796, ECO:0000269|PubMed:8449405}. |Branch| |N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity| |maintenance of lens transparency| |positive regulation of heterotypic cell-cell adhesion| |regulation of heterotypic cell-cell adhesion| |positive regulation of epithelial to mesenchymal transition| |negative regulation of cell-substrate adhesion| |regulation of epithelial to mesenchymal transition| |transforming growth factor beta receptor signaling pathway| |glycosaminoglycan biosynthetic process| |aminoglycan biosynthetic process| |cellular response to transforming growth factor beta stimulus| |glycosaminoglycan metabolic process| |response to transforming growth factor beta| |positive regulation of protein kinase B signaling| |aminoglycan metabolic process| |tissue homeostasis| |transmembrane receptor protein serine/threonine kinase signaling pathway| |positive regulation of ERK1 and ERK2 cascade| |regulation of cell-substrate adhesion| |regulation of protein kinase B signaling| |positive regulation of cell-cell adhesion| |protein glycosylation| |macromolecule glycosylation| |glycosylation| |negative regulation of cell adhesion| |regulation of ERK1 and ERK2 cascade| |glycoprotein biosynthetic process| |multicellular organismal homeostasis| |anatomical structure homeostasis| |glycoprotein metabolic process| |regulation of cell-cell adhesion| |positive regulation of cell adhesion| |positive regulation of cell migration| |cellular response to growth factor stimulus| |positive regulation of cell motility| |posttranscriptional regulation of gene expression| |response to growth factor| |positive regulation of cellular component movement| |positive regulation of MAPK cascade| |positive regulation of locomotion| |Golgi membrane| |carbohydrate derivative biosynthetic process| |regulation of cell adhesion| |enzyme linked receptor protein signaling pathway| |regulation of MAPK cascade| |regulation of cell migration| |regulation of cell motility| |positive regulation of cell population proliferation| |positive regulation of cell differentiation| |regulation of locomotion| |Golgi apparatus| |regulation of cellular component movement| |positive regulation of protein phosphorylation| |positive regulation of intracellular signal transduction| |carbohydrate derivative metabolic process| |positive regulation of phosphorylation| |positive regulation of phosphate metabolic process| |positive regulation of phosphorus metabolic process| |cellular response to endogenous stimulus| |positive regulation of protein modification process| |positive regulation of developmental process| |organonitrogen compound biosynthetic process| |regulation of protein phosphorylation| |response to endogenous stimulus| |regulation of phosphorylation| |positive regulation of cellular protein metabolic process| |regulation of cell population proliferation| |homeostatic process| |positive regulation of signal transduction| |positive regulation of protein metabolic process| |cellular macromolecule biosynthetic process| |positive regulation of multicellular organismal process| |macromolecule biosynthetic process| |regulation of phosphate metabolic process| |regulation of phosphorus metabolic process| |regulation of cell differentiation| |positive regulation of cell communication| |positive regulation of signaling| |regulation of intracellular signal transduction| |regulation of protein modification process| |membrane| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp475|CyclicAMP 200μM R08 exp475]]|-1.91| |[[:results:exp530|Thioridazine 5μM R08 exp530]]|1.71| |[[:results:exp48|Mubritinib 0.2μM R01 exp48]]|1.8| |[[:results:exp234|Ethanol 0.01 R05 exp234]]|1.99| |[[:results:exp273|Cisplatin 0.35μM R06 exp273]]|2.02| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 13847 * **Expression level (log2 read counts)**: 2.28 {{:chemogenomics:nalm6 dist.png?nolink |}}